Health Beat on Action 7 NewsKOAT health expert Dr. Barry Ramo said those can be night sweating, poor sleep and hot flashes. The FDA’s approval of Veozah marks a significant step forward in managing this debilitating condition that affects millions of women worldwide. **Main points:**
* Veozah is a new drug approved by the FDA for treating moderate to severe hot flashes related to menopause. * 75% of women experience menopause symptoms.

* A new drug called Veozah has been approved by the FDA for treating moderate to severe hot flashes associated with menopause. * Veozah is a prescription medication that works by blocking the action of a hormone called serotonin. * The drug is expected to be available in pharmacies nationwide. * About 75% of women experience hot flashes during menopause. * Veozah is a potential breakthrough for women struggling with menopause symptoms. **Detailed Text:**

Menopause, a natural biological process marking the end of a woman’s reproductive years, often brings a host of uncomfortable symptoms.

The side effects are not always predictable and can be severe. The drug is being used in a clinical trial for a specific condition, but it is not yet approved for general use. It is important to understand that the drug is not a cure for the condition, but rather a treatment that can help manage symptoms. It is also important to be aware of the potential risks and benefits of the drug before using it.